Literatur
-
1 Diener H C. et al .Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Thieme Verlag KG; 2008. http://(www.dgn.org)
-
2
Hughes A J, Daniel S E, Kilford L et al.
Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases.
J Neurol Neurosurg Psychiatry.
1992;
55 (3)
181-184
-
3
Litvan I, Goetz C G, Jankovic J et al.
What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study.
Arch Neurol.
1997;
54
937-944
-
4 Oertel W H, Schulz J B. Parkinson-Syndrome. In Brandt T, Dichgans J, Diener H C, (Hrsg) Therapie und Verlauf neurologischer Erkrankungen.. Stuttgart: Kohlhammer; 2003: 919-963
-
5
Hummel T, Sekinger B, Wolf S R et al.
„Sniffin’ sticks”: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold.
Chem Senses.
1997;
22
39-52
-
6
Wenning G K, Shephard B, Hawkes C et al.
Olfactory function in atypical parkinsonian syndromes.
Acta Neurol Scand.
1995;
91
274-250
-
7
Mueller A, Reichmann H, Livermore A et al.
Olfactory function in idiopathic Parkinson’s disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients.
J Neural Transm.
2002a;
109
805-811
-
8
Mueller A, Muengersdorf M, Reichmann H et al.
Olfactory function in parkinsonian syndromes.
J Clin Neurosc.
2002b;
9
521-524
-
9
Ondo W G, Lai D.
Olfaction testing in patients with tremor dominant Parkinson’s disease. Is this a distinct condition?.
Mov Disord.
2005;
20
471-475
-
10
Katzenschlager R, Lees A J.
Olfaction and Parkinson’s syndromes: its role in differential diagnosis.
Curr Opin Neurol.
2004;
17
417-423
-
11
Katzenschlager R, Zijlmans J, Evans A et al.
Olfactory function distinguishes vascular parkinsonism from Parkinson’s disease.
J Neurol Neurosurg Psychiatry.
2004;
75
1749-1752
-
12
Khan N L, Katzenschlager R, Watt H et al.
Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease.
Neurology.
2004;
62
1224-1226
-
13
Hawkes C H.
Olfaction in neurodegenerative disorder.
Mov Disord.
2003;
18 (4)
364-372
-
14
Doty R L, Singh A, Tertrud L et al.
Lack of major olfactory dysfunction in MPTP-induced parkinsonism.
Ann Neurol.
1992;
32
97-100
-
15
Herting B, Schulze S, Reichmann H et al.
A longitudinal study of olfactory function in patients with idiopathic Parkinson’s disease.
J Neurol.
2008;
255 (3)
367-370
-
16
Doty R L, Deems D A, Steller S.
Olfactory dysfunction in parkinsonism: A general deficit unrelated to neurologic signs, disease stage, or disease duration.
Neurology.
1988;
38
1237-1244
-
17
Hawkes C H, Shephard B C, Daniel S E.
Is Parkinson’s disease a primary olfactory disorder?.
Qjm.
1999;
92
473-480
-
18
Ponsen M M, Stoffers D, Booji J et al.
Idiopathic hyposmia as a preclinical sign of Parkinson’s disease.
Ann Neurol.
2004;
56
173-181
-
19
Haehner A, Hummel T, Hummel C et al.
Olfactory loss may be a first sign of idiopathic Parkinson’s disease.
Mov Disord.
2007;
22 (6)
839-842
-
20
Braak H, Tredici K D, Rub U et al.
Staging of brain pathology related to sporadic Parkinson’s disease.
Neurobiol Aging.
2003;
24
197-211
-
21
Braak H, Vos de R, Bohl J et al.
Gastric alpha-synuclein immunreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology.
Neuroscience Letters.
2006;
396
67-72
-
22
Huisman E, Uylings H B, Hoogland P V.
A 100 % increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson’s disease.
Mov Disord.
2004;
19 (6)
687-692
-
23
Sommer U, Hummel T, Cormann K et al.
Detection of presymptomatic Parkinson’s disease: Combining smell test, transcranial sonography, and SPECT.
Mov Disord.
2004;
19 (10)
1196-1202
-
24
Berendse H W, Booij J, Francot C M J et al.
Subclinical dopaminergic dysfunction in asymptomatic Parkinson disease patients’ relatives with decreased sense of smell.
Ann Neurol.
2001;
50
34-41
-
25
Stiasny-Kolster K, Doerr Y, Moller J C et al.
Combination of ‘idiopathic’ REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.
Brain.
2005;
128 (Pt 1)
126-137
-
26
Postuma R B, Lang A E, Massicotte-Marquez J et al.
Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder.
Neurology.
2006;
66
845-851
-
27
Berg D.
Marker for a preclinical diagnosis of Parkinson’s disease as a basis for neuroprotection.
J Neural Transm.
2006;
71 (Suppl)
123-132
-
28
Stern M B.
The preclinical detection of Parkinson’s disease: ready for prime time?.
Ann Neurol.
2004;
56
169-171
-
29
Berendse H W, Ponsen M M.
Detection of preclinical Parkinson’s disease along the olfactory tract.
J Neural Transm.
2006;
70 (Suppl)
321-325
PD Dr. med. Birgit Herting
Klinik für Neurologie Diakonie-Klinikum gGmbH
Diakoniestraße 10
74523 Schwäbisch Hall
Email: birgit.herting@dasdiak.de
